Answers are grounded in this paper and cite their sources.
T cells, which could be mediated by Lck phosphorylation. Further, CP-25, via its ability to modulate Lck, is a novel potential therapeutic agent for the treatment of human autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: